Before House hearing, Sanofi cuts insulin prices for some patients

Before House hearing, Sanofi cuts insulin prices for some patients

Source: 
Stat
snippet: 

Just hours before one of its executives is set to testify at a Congressional hearing to review insulin pricing, Sanofi (SNY) on Wednesday offered a program that will lower the cost of the diabetes treatment to $99 a month for uninsured patients and others who pay cash in the U.S.